Completed PHASE1 INTERVENTIONAL 4-arm NCT01899378

Safety and Efficacy of Probiotics in Bangladeshi Infants

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions Healthy

Interventions Bifidobacterium longum infantis Lactobacillus reuteri DSM 17938

Updated 5 times since 2017 Last updated: Oct 13, 2016 Started: Oct 31, 2013 Primary completion: Jul 31, 2014 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. International Centre for Diarrhoeal Disease Research, Bangladesh leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Centre for Diarrhoeal Disease Research, Bangladesh
Stanford University
Thrasher Research Fund

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh